HOPE‑3, BP treatment, milestones in CV prevention. Dr. Salim Yusuf in an interview with Dr. Akbar Panju and Dr. Roman Jaeschke
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- December 22, 2016
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- 1117 Public Health and Health Services (FoR)
- Antihypertensive Agents (MeSH)
- Cardiovascular Diseases (MeSH)
- Cardiovascular System & Hematology (Science Metrix)
- Clinical Trials as Topic (MeSH)
- Drug Therapy, Combination (MeSH)
- Humans (MeSH)
- Hydroxymethylglutaryl-CoA Reductase Inhibitors (MeSH)
- Hyperlipidemias (MeSH)
- Hypertension (MeSH)
- Practice Guidelines as Topic (MeSH)
- Treatment Outcome (MeSH)